Emergent BioSolutions Inc. (EBS)
NYSE · Healthcare
Emergent BioSolutions Inc. Operating Income 2009–2025
Emergent BioSolutions Inc. annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Emergent BioSolutions Inc. operating income for the quarter ending March 31, 2026 was 10.5 M, a 78.96% decrease year-over-year.
- Emergent BioSolutions Inc. operating income for the twelve months ending March 31, 2026 was 138.5 M, a 140.58% decrease year-over-year.
- Emergent BioSolutions Inc. annual operating income for 2025 was 100.1 M, a 192.09% decrease from 2024.
- Emergent BioSolutions Inc. annual operating income for 2024 was -108.7 M, a 85.04% decrease from 2023.
- Emergent BioSolutions Inc. annual operating income for 2023 was -726.4 M, a 327.29% increase from 2022.
- Emergent BioSolutions Inc. annual operating income for 2022 was -170.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Emergent BioSolutions Inc. Operating Income — FAQ
Emergent BioSolutions Inc. (EBS) operating income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Emergent BioSolutions Inc.'s operating income?
Emergent BioSolutions Inc. (EBS) reported operating income of $100M for fiscal 2025.
Where can I see EBS's operating income history?
The chart and table above show Emergent BioSolutions Inc.'s operating income by year and by quarter, including the growth rate.